Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Hubben

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood|May 16, 2024
A "backup plan" for ADAMTS13 deficiency in TTPAnne Hubben, Keith R McCrae
Hematology. American Society of Hematology. Education Program|December 9, 2023
How to diagnose and manage antiphospholipid syndromeAnne Hubben, Keith R McCrae
Transfusion Medicine Reviews|October 22, 2022
Emerging Therapies in Antiphospholipid SyndromeAnne Hubben, Keith R McCrae
Targeted Oncology|July 11, 2019
The Role of Checkpoint Inhibitors in GlioblastomaKunal Desai, Anne Hubben, Manmeet Ahluwalia
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Annals of Hematology|August 9, 2019
Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case seriesTahani Atieh, Anne Hubben, Beth Faiman, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2025
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndromeAnne Hubben, Jenna Brown, Linda Burke, et al.
Blood Vessels, Thrombosis & Hemostasis|April 7, 2025
Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathyChen Lossos, Jenna Brown, Sara Sheikhbahaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2019
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic ReviewZabih Warraich, Pavan Tenneti, Theresa Thai, et al.
Bone Marrow Transplantation|February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF aloneAnne Hubben, Danai Dima, Tahani Atieh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|May 16, 2024
A "backup plan" for ADAMTS13 deficiency in TTPAnne Hubben, Keith R McCrae
Hematology. American Society of Hematology. Education Program|December 9, 2023
How to diagnose and manage antiphospholipid syndromeAnne Hubben, Keith R McCrae
Transfusion Medicine Reviews|October 22, 2022
Emerging Therapies in Antiphospholipid SyndromeAnne Hubben, Keith R McCrae
Targeted Oncology|July 11, 2019
The Role of Checkpoint Inhibitors in GlioblastomaKunal Desai, Anne Hubben, Manmeet Ahluwalia
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Annals of Hematology|August 9, 2019
Pomalidomide-based maintenance post-autologous hematopoietic cell transplantation in multiple myeloma: a case seriesTahani Atieh, Anne Hubben, Beth Faiman, et al.
Research and Practice in Thrombosis and Haemostasis|December 17, 2025
The Patient-Reported Outcomes Measurement Information System perspective of adults with long-standing atypical hemolytic uremic syndromeAnne Hubben, Jenna Brown, Linda Burke, et al.
Blood Vessels, Thrombosis & Hemostasis|April 7, 2025
Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathyChen Lossos, Jenna Brown, Sara Sheikhbahaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2019
Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic ReviewZabih Warraich, Pavan Tenneti, Theresa Thai, et al.
Bone Marrow Transplantation|February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF aloneAnne Hubben, Danai Dima, Tahani Atieh, et al.
Pageof 1